Karen Knudsen: Thank you to the NYSE for standing with the American Cancer Society
Karen Knudsen shared the following on LinkedIn:
“Finally, a heartfelt thank you to the NYSE for transforming today’s trading floor into a beacon of hope for ending cancer as we know it, for everyone. We are so grateful and truly appreciate you, and the many corporate partners represented on your ticker. Thank you for standing with the American Cancer Society!”
Source: Karen Knudsen/LinkedIn
More posts featuring Karen Knudsen on oncodaily.com
Dr. Karen E. Knudsen is the Chief Executive Officer of the American Cancer Society and the American Cancer Society Action Network. She is also a member of the Board of Directors at Research!America. Additionally, Dr. Knudsen serves on the Scientific Review Board at Genentech and has been a board member and as a member of the Board of Scientific Advisors at the National Cancer Institute (NCI). Dr. Knudsen is known for her practice-changing research in prostate cancer, which has contributed to new, effective cancer treatments.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023